Medicare CoverageMedicare coverage appears imminent, which could lead to a significant increase in test volume and revenue from Medicare patients and benefit commercial/private payer adoption.
Potential AcquisitionEsoGuard's huge first mover advantage and better test makes Lucid a very attractive potential acquisition candidate.
Strategic PartnershipsLUCD partnered with a major health system to expand access to its EsoGuard testing program, which is expected to broaden adoption and drive topline growth.